IL6 and chronic kidney disease: Inflammation plays a key role in muscle atrophy in CKD, with increased levels of pro-inflammatory cytokines like tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) driving muscle degradation (32, 33).